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Abstract
Introduction
Knowledge of ovine mesenchymal stromal cells (oMSCs) is currently expanding. Tissue
engineering combining scaffolding with oMSCs provides promising therapies for the treat-
ment of osteochondral diseases.
Purpose
The aim was to isolate and characterize oMSCs from bone marrow aspirates (oBMSCs)
and to assess their usefulness for osteochondral repair using β-tricalcium phosphate
(bTCP) and type I collagen (Col I) scaffolds.
Methods
Cells isolated from ovine bone marrow were characterized morphologically, phenotypically,
and functionally. oBMSCs were cultured with osteogenic medium on bTCP and Col I scaf-
folds. The resulting constructs were evaluated by histology, immunohistochemistry and
electron microscopy studies. Furthermore, oBMSCs were cultured on Col I scaffolds to
develop an in vitro cartilage repair model that was assessed using a modified International
Cartilage Research Society (ICRS) II scale.
Results
oBMSCs presented morphology, surface marker pattern and multipotent capacities similar
to those of human BMSCs. oBMSCs seeded on Col I gave rise to osteogenic neotissue.
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Assessment by the modified ICRS II scale revealed that fibrocartilage/hyaline cartilage was
obtained in the in vitro repair model.
Conclusions
The isolated ovine cells were demonstrated to be oBMSCs. oBMSCs cultured on Col I
sponges successfully synthesized osteochondral tissue. The data suggest that oBMSCs
have potential for use in preclinical models prior to human clinical studies.
Introduction
Articular cartilage and its supporting bone are tightly coupled, forming a connected osteo-
chondral unit [1]. Orthopaedic surgeons have recently focused on the treatment of osteochon-
dral lesions because most of these lesions do not heal spontaneously and can develop into
osteoarthritis [1, 2]. Several treatment approaches have been tested, including osteochondral
autologous transplantation or microfracture [3, 4]. However, none of the currently available
approaches have achieved clinical acceptance for repair of the osteochondral unit [1, 5, 6]. This
lack of effective treatment motivates research into the tissue engineering of a biological
implant to replace the diseased joint [7, 8]. In tissue engineering, scaffolds are indispensable as
carriers of cells at the injured site that stimulate neotissue formation [9]. In addition, scaffolds
provide a comfortable niche for cells, stimulating them to synthesize matrix and replace the
function of the native tissue [10].
β-tricalcium phosphate (bTCP) is an absorbable ceramic that has been widely used for bone
reconstruction due to its bioactive and osteoconductive properties [11–13]. On the other
hand, type I collagen (Col I) is inherently biocompatible and biodegradable and promotes cel-
lular adhesion and proliferation [14]. For these properties Col I has been extensively tested for
both bone and cartilage repair [2, 15].
In most studies, scaffolds have been used in combination with cells from different sources.
Mesenchymal stromal cells (MSCs) have become attractive for cartilage and bone tissue engi-
neering [15] because of their easy isolation, expansion, self-renewal ability and multipotential
differentiation properties [16, 17]. Therapies based on MSCs or MSC-derived products to treat
human diseases have yet to be tested in large animal models before starting clinical trials [18].
Preclinical studies in orthopaedic research using sheep as a large animal model are becom-
ing common [2, 18–24]. This is due to the marked similarities of the sheep with human bone/
cartilage regeneration processes, joint structure, and weight bearing; thus ovine large animal
models have potential in translational research [24, 25].
Knowledge of ovine MSCs is recently increasing and the sheep genome sequence was
recently completed [26], aiding in obtaining understanding of these cells. However, characteri-
zation of ovine MSCs is not well established [19] and controversy exists among the results [27].
To date, most cartilage/bone engineering studies developed in both animal and human
models have shown heterogeneous results [28] and the analyses have usually focused at the
neotissue level, not at the cellular level.
In this work we performed an ovine bone marrow MSC (oBMSCs) characterization using
surface marker expression and multipotent differentiation. The osteogenesis of oBMSCs cul-
tured on bTCP and Col I scaffolds was tested in depth by histological and ultrastructural analy-
ses. Moreover, the chondrogenic repair capacity of oBMSCs cultured on Col I scaffolds was
evaluated using an in vitro cartilage repair model.
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Materials and Methods
Ovine sample procurement
This study was approved in accordance with the Ethics Committee for Animal Experimenta-
tion of the CHUAC. For all experiments mixed breed of domestic sheep (Ovis aries) at an age
of 1 to 6 years were used (males and females from 5150760107901, Lamas, A Coruña, Spain)
(n = 7, 5 females and 2 males). The animals were housed in the veterinary care facility under
standardized conditions of humidity and temperature with a 12 h light/dark rhythm. Animals
included in this research were slaughtered in accordance with the guidelines of the Experimen-
tal Surgery Unit of the Training Technology Centre from Complexo Hospitalario Universi-
tario de A Coruña (CHUAC), Spain.
Bone marrow samples used to obtain oBMSCs were isolated from iliac crest aspirates of
sheep (n = 6). Samples of femoral condyles were obtained from previously slaughtered sheep
(n = 3).
Isolation and culture of ovine bone marrow stromal cells
Iliac crest bone marrow aspirates were collected into centrifuge tubes (Costar Corning Incorpo-
rated, New York, USA) and centrifuged after clotting with culture medium (Dulbecco’s Modi-
fied Eagle’s Medium; DMEM; Lonza, Madrid, Spain) supplemented with 5% fetal bovine
serum (FBS; Gibco- Thermo Fisher Scientific, Madrid, Spain) and 1% penicillin/streptomycin
(P/S; Gibco) (5%FBS/DMEM). The supernatants were discarded. Under sterile conditions, the
marrow clots were divided with tweezers into several parts on adherent culture plates (Costar
Corning Incorporated) and grown in culture medium 20%FBS/DMEM at 37˚C in a humidified
atmosphere with 5% CO2.
After 48 hours, the plates were washed with sterile saline solution (Fresenius Kabi, Barce-
lona, Spain), eliminating non-adherent cells and clots, and culture medium was added. The
culture medium was then replaced every 3 days.
When cell confluence reached 80%, subculturing was performed for cell expansion. A
15-min preplating technique [29] was performed at the first cell passage to eliminate any
remaining macrophages or fibroblasts from the culture.
At the 2nd-8th passages, cells were used for morphological, phenotypical and functional cul-
ture studies.
Phenotypic characterization using flow cytometry
At passages 3rd, 4th, and 8th after culture expansion, cells from 3 animals were analyzed by flow
cytometry. A total of 2x105 cells were transferred to fluorescence-activated cell sorting (FACS)
polypropylene tubes (NUNCTM, VWR International, Radnor, Pennsylvania). The antibodies
used for these experiments are listed in Table 1. The antibodies used are specific for markers
associated with mesenchymal and hematopoietic lineages. A minimum of 1x105 cell events per
assay was acquired using a FACsCalibur flow cytometer (BD Biosciences, Madrid, Spain). Data
were analyzed using Cell Quest software (BD Biosciences) and the results are expressed as
mean of positive percentage ± standard error.
Multipotential characterization of ovine bone marrow stromal cells
At 2nd-5th passages, oBMSCs from 3 animals were differentiated towards the three mesenchy-
mal lineages: adipocyte, osteoblast and chondrocyte.
Adipogenic and osteogenic differentiation. oBMSCs were seeded at 5x103 cells/cm2 in a
chamber slide (BD FalconTM, BD Biosciences) for histology (n = 4) and at 50x103 in a 6-well-
Osteochondral Tissue Engineering
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plate (Costar Corning Incorporated) for molecular analyses (3 independent samples). Adipo-
genesis was induced by culturing for 21 days in human MSC (hMSC) Commercial Adipogenic
Differentiation Medium (Lonza), following the manufacturer’s instructions, with 1ng/ml of
Rosiglitazone (Sigma Aldrich Quimica SA) added. Osteogenesis was induced by culture for 21
days in hMSC Commercial Osteogenic Differentiation Medium (Lonza), following the manu-
facturer’s instructions.
Both adipogenic and osteogenic differentiations were compared to a control consisting of
cells cultured for the same period of time in 20% FBS/DMEM. Differentiations were con-
firmed by staining techniques and gene expression quantification using Real Time-PCR
(qPCR).
Table 1. Antibodies used for flow cytometry.
ISOTYPES
Antibody Clone Specificity Source
FITC Mouse IgG1Kappa Isotype Control MOPC-21 BD PharmingenTM
PE Mouse IgG1 Kappa Isotype Control MOPC-21 DB PharmingenTM
PECy5 Mouse IgG1 Isotype Control 1F8 Abcam
Rabbit anti-mouse Inmunoglobulins/FITC DAKO
LABELED PRIMARY ANTIBODIES
PE Mouse Anti-Human CD34 monoclonal 581 Hematopoietic progenitor cell antigen 1 (HPCA1) BD PharmingenTM
Mouse Anti-Sheep CD44:FITC monoclonal 25.32 Homing cellular adhesion molecule (HCAM) AbD Serotec
PE Anti-Human CD29-PE monoclonal TS2/16 β1 Integrin BioLegend
FITC Mouse Anti-Rat CD45 monoclonal OX-33 Leukocyte common antigen (LCA) BD PharmingenTM
FITC Mouse Anti-Human CD45 monoclonal HI30 LCA BD PharmingenTM
PE Rat Anti-Mouse CD45 monoclonal 30-F11 LCA BD PharmingenTM
Purified Mouse Anti-Human CD69 monoclonal FN50 Very early activation antigen BD PharmingenTM
PE Mouse Anti-Human CD73 monoclonal AD2 Esto-5´-nucleotidase BD PharmingenTM
PE-CyTM5 Mouse Anti-Human CD90
monoclonal
5E10 Thy-1 membrane glycoprotein BD PharmingenTM
Mouse Anti-Human CD105:FITC monoclonal SN6 Endoglin, SH2 AbD Serotec
PE-CyTM5 Mouse Anti-Human CD106
monoclonal
51-10C9 Vascular cell adhesio´n molecule 1 (VCAM-1) BD PharmingenTM
PE Mouse Anti-Human CD166-PE monoclonal 3A6 Activated leukocyte cell adhesion molecule
(ALCAM)
Immunostep
NON-LABELED PRIMARY ANTIBODIES
Mouse Anti-Human CD45 monoclonal MEM-28 LCA Abcam
Anti-CD90 MRC OX-7 Thy1 Abcam
Rabbit anti-CD90 polyclonal Thy1 Antibodies-online.com
Mouse Anti-Human CD105 105C02 SH2 Abcam
Mouse Anti-Human CD271 monoclonal ME20.4 Anti-Nerve Growth Factor Receptor (NGFR p75) Sigma
Anti-Human/Mouse SSEA-4 monoclonal MC-813-
70
Stage-specific embryonic antigen 4 (SSEA-4) R&D Sytems
Mouse Anti-Human STRO-1 NS1-Ag4-1 Stromal antigen 1 (STRO-1) Developmental Studies Hybridoma
Bank
SECONDARY ANTIBODIES
Rabbit Anti-Mouse Immunoglobulins/FITC DAKO
Goat anti-rabbit IgG-PE Santa Cruz Biotechnology, INC.
Antibodies used for phenotypical characterization by flow cytometry. FITC = Fluorescein isothiocyanate; PE = Phycoerythrin.
doi:10.1371/journal.pone.0171231.t001
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Chondrogenic differentiation. Chondrogenesis was assessed using the micropellet for-
mation (2.5x105 cells) technique [30]. oBMSCs (from 3 independent samples) pellet was cul-
tured in hMSC Commercial Chondrogenic Differentiation Medium (Lonza) with 10 ng/ml of
human transforming growth factor (TGFβ-3) (Prospec-Tany Technogene Ltd., Rehovot, Israel)
for 21 days, following the manufacturer’s instructions. Chondrogenic differentiation was com-
pared with cell micropellets cultured for the same period of time with 20% FBS/DMEM. After
21 days, two cell aggregates were OCT (Tissue-Tek cryo-OCTcompound, Thermo Fisher Scien-
tific) embedded and frozen for histology and three cell micropellets were frozen, without OCT,
for molecular analyses.
Bone and cartilage engineering
Two different types of scaffolds were used: horse tendon Col I sponges and bTCP synthetic
ceramic. Col I sponges (6 mm diameter x 1 mm thick) were supplied by the Italian company,
Opocrin, SPA, Corlo di Formigine-Modena. They were used to test both osteogenic differentia-
tion and chondrogenic repair capacities.
1000–2000 μm grain bTCP (Macrobone, Euroteknika Iberia, Barcelona, Spain) was provided
by the Instituto Coruñe´s de Implantologı´a y Rehabilitacio´n Oral (ICIRO) and used to test oste-
ogenic differentiation.
Osteogenic differentiation on Col I sponges and on beta-tricalcium
phosphate ceramic
oBMSCs from 3 animals at the 3rd passage were cultured on the surface of sponges (200,000
cells/cm2) (2 replicates) and oBMSCs (2x105) from 3 animals at the 4th passage were also cul-
tured with 100 mg of grain 1000–2000 μm bTCP ceramic (2 replicates), both for 30 days. Oste-
ogenic differentiation was induced by culturing the oBMSCs in hMSC Commercial Osteoge-
nic Differentiation Medium, following the manufacturer’s instructions. In addition, each type
of scaffold, without cells, was cultured in the same medium and for the same period of time to
serve as a negative control.
Cartilage lesion repair using Col I sponges. Ovine cartilage was obtained from femoral
condyles (from 3 animals) and excised with a 6 mm biopsy punch (7 discs; Kai Medical,
Solingen, Germany). Lesions (3 mm) were made with a dental driller (Gebr. Brasseler Gmbh &
Co. KQ, Lemgo, Germany) with a rotor (EWL K9).
oBMSCs (2x105) from 2 animals (4th passage) were seeded on Col I sponges for 30 min at
37˚C, and the construct was then placed inside the lesion. Punches were cultured for 8 weeks
using hMSC Chondrogenic Differentiation Medium with 10 ng/ml of human TGFβ-3.
Molecular analysis of cell differentiation
Differentiation of oBMSCs towards the three mesenchymal lineages (adipocyte, osteoblast and
chondrocyte) was analyzed using molecular biology techniques.
Isolation of total RNA from cell culture was accomplished using Trizol Reagent (Invitro-
genTM—Thermo Fisher Scientific), following the manufacturer’s protocol. RNA was assessed
for quantity at 260 nm using a NanoDropTM spectrophotometer (Thermo Fisher Scientific).
The RT-PCR reaction was performed from total RNA following the manufacturer’s instruc-
tions, using the SuperScriptTM First-Strand Synthesis System for RT-PCR (Invitrogen TM) in a
Thermocycler (Gene Amp PCR System 9700,Applied Biosystems—Thermo Fisher Scientific).
qRT-PCR analyses were performed, using the primers and conditions shown in Table 2, on
a LightCycler1 480 Instrument (Roche, Basel, Switzerland) using LightCycler 480 SYBR Green
I Master (Roche), following manufacturer’s instructions.
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Data analysis was performed for triplicates using the LightCycler 480 Relative Quantifica-
tion software (Roche) and REL were calculated by the 2-ΔΔCt method [31].
Cytological and histological analyses
Assessment of adipogenic, osteogenic and chondrogenic differentiation of oBMSCs.
For adipogenesis evaluation, differentiation was confirmed by detection of cytoplasmic lipid
droplets by Oil red O (OR-O) staining. For osteogenesis evaluation, differentiation was ana-
lyzed by Alizarin red (AR) staining, to assess the presence of calcium deposits.
For chondrogenesis evaluation, cell aggregates were stained with hematoxylin and eosin
(HE), Masson’s trichrome (MT), PAS-Alcian blue (PAS-AB) and Safranin O (SO) for Col and
proteoglycans (PG). Moreover, inmunostaining for Col I, Col II and aggrecan (Agg) (Table 3)
was performed. The peroxidase/DAB ChemMateTM DAKO EnVisionTM detection kit (Dako,
Barcelona, Spain) was used.
Assessment of osteogenic constructs and chondrogenic lesion repair. Assessment of
osteogenic constructs and chondrogenic lesion repair was performed by histology and electron
microscopy analyses.
Osteogenic cell and cell-free scaffolds, and chondrogenic repair models were fixed in 4%
formaldehyde and embedded in paraffin.
To evaluate osteogenic constructs, samples were decalcified and stained with HE, Von
Kossa (VK) and AR. Immunostaining for Col I and osteocalcin (OCN) was also performed.
Table 2. Primers used for the relative expression (REL) of typical genes for differentiation and multipotency.
Gene name Primer Sequences Product size Reference Sequence
GAPDH 5’ ATCCTGCCAACATCAAGTGG 3’ 84 nt NM_001190390.1
5’ CAGCCTTCTCCATGGTAGTGA 3’
VIM 5’ ACATCGAGATCGCCACCTAC 3’ 100 nt KC904793.1
5’ TTGGTTTCCCTCAGGTTCAG 3’
SOX2 5’ CGAGGGAATGGACCTTGTATAG 3’ 88 nt X96997.1
5’ CTGCAAAGCTCCTACCGTATC 3’
LPL 5’ TGAAACTTGGCAAAGCTACAGA 3’ 78 nt DQ016298.1
5’ GGCGTCTTTTGTAAAAGTTACCTCAT 3’
FABP4 5’ GGATGTGGTCAACATTAAATCAGA3’ 95 nt EU301804.1
5’ TGTCATCTGGAGTGACTTCATCA 3’
OP 5’ GCAGTCCTCACTGTCACAAGA 3’ 105 nt AF152416.1
5’ TGCTGTGGAATTAGCAGTCG 3’
OCN 5’ GAAGAGACTCAGGCGCTACCT 3’ 107 nt DQ418490.1
5’ CATCACAGTCAGGGTTGAGC 3’
AGG 5’ TTTGGACTTTGGCAGAATACC 3’ 78 nt FJ200438.1
5’ AATCCAGAAGGAAGACCACTTG 3’
COL II 5’ GGGCGAGACTGTGATTGAGT 3’ 118 nt FJ378650.1
5’ GACAGGCCCTATGTCCACAC 3’
COL I 5’ CCTGGATGCCATTAAGGTCT 3’ 113 nt AF129287.1
5’ TCTTGTCCTTGCTCTTGCTG 3’
Product size in nucleotides (nt) and GenBank reference. Housekeeping gene: Glyceraldehyde-3-phosphate Dehydrogenase (GAPDH). To evaluate grade
of multipotency: Vimentin (VIM) and SRY (sex-determining region Y)-box 2 (SOX2). For adipogenesis: Lipoprotein Lipase (LPL) and Fatty Acid Binding
Protein 4 (FABP4). For osteogenesis: secreted Phosphoprotein 1 (OP) and Osteocalcin (OCN). For chondrogenesis: Aggrecan (AGG) and type II Col alpha
1 (COL II). For fibroblasts: type I Col alpha 1(COL I).
doi:10.1371/journal.pone.0171231.t002
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For cartilage repair evaluation, samples were stained as described for “Chondrogenesis eval-
uation”. For assessment of the quality of ovine cartilage repair, the histology scoring system,
ICRS II, which was designed for use in human cartilage repair evaluation, was used. Some
modifications to this grading system were made for adaptation for the analysis of ovine carti-
lage repair. Our modified score system comprised 7 of the 14 ICRS II parameters [32].
Quantitative analyses of the staining and immunostaining described above were measured
using ImageJ 1.48v (National Institutes of Health, Bethesda, USA). After the colour substraction
of non-stained and counterstained regions, the percentage of stained area was measured and
expressed as mean ± standard error. Also, NIS-elements AR 3.0 software (Nikon, Netherlands)
was used for AR quantification.
Samples for electron microscopy were processed in the Servizode Apoio á Investigación at the
University of A Coruña (SAI-UDC). For scanning electron microscopy (SEM), scaffolds were
first fixed in 3% glutaraldehyde in cacodylate buffer. Before further fixation in osmium tetroxide,
the scaffolds were dehydrated in a graded series of ethanol. Samples were critical-point dried by
flooding with liquid CO2 in a Bal-Tec CPD 030 (BAL-TEC, Balzers, Liechtenstein) and gold-
sputtered with the coater Bal-Tec SCD 004 (BAL-TEC). Samples were observed using a scanning
electron microscope, JSM 6400 (JEOL, Tokyo, Japan). For transmission electron microscopy
(TEM) scaffolds were first fixed in 3% glutaraldehyde in cacodylate buffer and dehydrated in a
graded series of acetone and then fixed in osmium tetroxide. Samples were embedded in Spurr
(Electron Microscopy Sciences,Hatfield, USA) and 2 μm sections were stained with toluidine blue
to confirm the presence of cells. Then, 60-nm-thick Spurr sections were made and observed
using a transmission electron microscope, Jeol JEM 1010 (JEOL). For Energy Dispersive X-ray
analysis (EDX), 5-μm-thick Spurr sections were obtained and deposited on a slide for SEM. Sam-
ples were coated with a thin layer of pure graphite carbon using BAL-TEC CEA 035 equipment
(BAL-TEC). Samples were subsequently analyzed using a scanning electron microscope (JEOL
JSM-6400, JEOL) equipped with a chemical microanalysis system through energy dispersive x-
ray OXFORD INCA ENERGY 200 (Oxford instruments, Abingdon, England).
Statistical analyses
All statistical analyses were performed with GraphPad Prism (GraphPad Software, Inc.), using
non-parametric tests (Mann-Whitney U and Kruskal- Wallis tests). p-values<0.05 are consid-
ered to be statistically significant. Results are expressed as the mean ± standard error.
Results
Morphologic characterization of oBMSCs
oBMSCs were successfully isolated from sheep bone marrow by puncture of the iliac crest. It
took 14±2 days for first passage cells and this cell population showed the typical spindle-shaped
fibroblast-like morphology characteristic of the MSC, with irregular cytoplasm and numerous
Table 3. Antibodies used for immunohistochemistry.
Antibody Clone Specificity Source
Anti-Collagen I monoclonal COL-I Type I Collagen Abcam
Anti-Collagen II monoclonal 5B2.5 Type II Collagen Abcam
Anti-Aggrecan ARGxx monoclonal BC-3 Aggrecan Abcam
Anti-Osteocalcin monoclonal OC4-30 Osteocalcin Abcam
Antibodies used for the analysis of chondrogenic and osteogenic differentiation by immunohistochemistry.
doi:10.1371/journal.pone.0171231.t003
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cytoplasmic prolongations (Fig 1A). The isolated oBMSCs also showed adherence to plastic in
culture and were very similar to those from human sources (Fig 1B)[33].
Immunophenotypic characterization of oBMSCs
Immunophenotypic analysis was performed to assess the expression of mesenchymal and
hematopoietic markers in isolated oBMSCs. This analysis was performed on cells from 3 sam-
ples at different passages (passage 3 through 8). The cell-surface antigen profile of oBMSCs
Fig 1. Morphologic and phenotypic characterization of oBMSCs. (A) Image of ovine bone marrow mesenchymal stromal cells at passage 5 and
8 isolated from iliac crest aspirates. (B) Image of human bone marrow mesenchymal stromal cells (hBMSCs) at passage 10 isolated from bone
marrow aspirates, as previously described [33]. Both images show the typical spindle-shaped fibroblast-like morphology characteristic of the MSC.
Original magnification x100. (C) Phenotypic characterization by flow cytometry of a representative population of oBMSCs, for markers characteristic
of MSCs and hematopoietic cells that react with sheep. The purple line signifies the specific antibody, while the orange line represents the isotype
control. Plots correspond to a representative experiment (D) Bar graph representing the percentage average values (mean ± standard error) of
positivity of the markers analyzed from 3 samples at different passages (at 3rd, 4th and 8th passages); markers characteristic of MSCs (CD29, CD44,
CD166), embryonic cells (SSEA-4), and hematopoietic cells (CD45).
doi:10.1371/journal.pone.0171231.g001
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was analyzed using antibodies directed against human (CD29, CD34, CD45, CD69, CD73,
CD90, CD105, CD106, CD166, CD271, SSEA4 and STRO1) and rat (CD45 and CD90) CD
surface markers because of the restricted number of antibodies are available for sheep (only
anti-sheep CD44 was used). Although oBMSCs have cell surface antigens similar to hBMSCs,
most antibodies reacting with hBMSCs did not show reactivity with oBMSCs (S1 File), despite
of checking several antibody clones (CD45, CD90 and CD105, S1A Fig). Three exceptions
were found (Fig 1C): CD29, which showed 87.58%±11.70% positivity; CD166, which showed
66.85%±8.79% positivity; and SSEA4, which showed 11.67%±11.31% positivity. Anti-sheep
CD44 showed 81.08%±16.68% positivity (S1 File). oBMSCs have shown to be negative for
CD45 (even when positive in ovine blood, S1B Fig), indicating no contamination with cells of
hematopoietic origin (Fig 1C).
In vitro differentiation potential of oBMSCs
Adipogenic differentiation of oBMSCs. Adipogenic differentiation was assessed by
OR-O staining at 0 and 21 days of culture in adipogenic medium (Fig 2A and 2B). Stimulated
oBMSCs showed positive staining with single adipocytic multivacuolar cells secreting lipid
droplets. However, 0 and 21 day- non-stimulated oBMSCs, showed the absence or much
weaker staining for lipids than stimulated oBMSCs (p = 0.001). Adipogenic differentiation was
also assessed by qRT-PCR (S1 File). The expression levels of the adipogenic lineage-specific
genes, LPL and FABP4, were studied. The expression levels of two multipotent-specific genes,
VIM and SOX2 (Fig 2C), were also assessed. oBMSCs stimulated for 21 days in adipogenic
medium showed an increased relative expression (REL) of the genes FABP4 and LPL in all the
three samples, compared with oBMSCs at day 0 of differentiation. Considering the expression
of the multipotency genes in the stimulated oBMSCs at 21 days, the expression levels of VIM
and SOX2 decreased compared with oBMSCs at day 0 day of differentiation in two out of
three samples (Sample 2 and 3, Fig 2C). Only one sample (Sample 1, Fig 2C) of oBMSCs cul-
tured for 21 days in control medium (20% FBS/DMEM) showed a decrease in the expression
of FABP4 and LPL, compared with oBMSCs at day 0 of differentiation. At 21 days in two out
of three oBMSCs (Sample 1 and 2, Fig 2C) cultured in control medium, we found that the
expression levels of VIM and SOX2 were decreased compared with oBMSCs at day 0 of
differentiation.
Osteogenic differentiation of oBMSCs. The osteogenic differentiation potential of
oBMSCs was examined by determining the presence of calcification using AR stain (Fig 3A
and 3B). 21-day-stimulated oBMSC populations showed extracellular calcium deposition.
Non-stimulated oBMSCs, maintained in control medium (20% FBS/DMEM) for 0 and 21
days, showed less positivity (p = 0.000) for AR staining.
Osteogenic differentiation was also assessed by qRT-PCR (S1 File). The expression level of
the osteogenic lineage-specific genes OP and OCN were studied. In addition, the expression
levels of multipotency-specific genes VIM and SOX2 (Fig 3C) were analyzed. oBMSCs stimu-
lated for 21 days in osteogenic medium showed an increased expression of OP and OCN in all
the three samples compared with oBMSCs at day 0 of differentiation. The expression levels of
SOX2 and VIM at 21 days were lower in two out of three oBMSCs stimulated samples (Sample 1
and 2, Fig 3C) than at 0 day of differentiation. oBMSCs cultured for 21 days in control medium
also showed an increased expression of OP compared with oBMSCs at day 0 of differentiation,
except in sample 1 (Fig 3C). In samples 1 and 3 (Fig 3C) the expression of VIM at 21 days in
20% FBS/DMEM was approximately the same as that of oBMSCs at day 0 of differentiation.
SOX2 gene expression in 21 days control medium compared to day 0 was variable among all
samples (Fig 3C).
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Chondrogenic differentiation of oBMSCs. Indicating chondrogenic differentiation, HE
staining revealed the rounded morphology of the micromass cultures. Stimulated micropellets
showed higher cellularity in the core than that found in non-stimulated cultures. However,
both possessed extracellular matrix (ECM), although total Col (Fig 4A, MT) and PG (Fig 4A,
PAS-AB and SO) were more abundant in stimulated cultures. Immunostaining for Col I and
II was also more prominent in the stimulated micropellets (Fig 4A, Col I and Col II).
Chondrogenic differentiation was also assessed by qRT-PCR (S1 File). The expressions of
the chondrogenic lineage-specific genes COL II and AGG were tested. To eliminate differenti-
ation towards fibroblasts, COL I was tested as well. Furthermore, the expression levels of two
multipotency-specific genes, VIM and SOX2 (Fig 4B), were also analyzed. oBMSCs stimulated
for 21 days in chondrogenic medium showed an increased expression of the genes AGG, COL
I and COL II, compared with oBMSCs at day 0 of differentiation in all the samples, excepting
sample 3, in which COL I decreased (Fig 4B). At 21 days, the expression level of SOX2 was
Fig 2. Adipogenic differentiation of oBMSCs. (A) Ovine bone marrow mesenchymal stromal cells (oBMSCs, n = 4, passages 2nd-5th) at day 0 (left) of
differentiation and cultured for 21 days in non-differentiation control medium (20% FBS/DMEM; middle) and adipogenic-differentiation medium (right). The
presence of adipocytes was assessed by detection of lipid drops using Oil Red O (OR-O) stain. Magnification x200. (B) Bar graph represents the percentage
of area positively stained for OR-O expressed as the mean ± standard error. * and ** indicates p<0.05. (C). mRNA levels were measured in three indepen-
dent samples (n = 3) by quantitative Real Time Polymerase Chain Reaction (qRT-PCR), as described in Materials and Methods. Data are expressed as
mean ± standard error of the relative expression (REL). The results are normalized to values obtained for oBMSCs at day 0 of differentiation, considered to
equal 1.
doi:10.1371/journal.pone.0171231.g002
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slightly increased in samples 1 and 3, whereas the expression level of VIM was decreased
in all the samples, compared with oBMSCs at day 0 of differentiation (Fig 4B). oBMSCs
from samples 2 and 3 cultured for 21 days in control medium did not show expression of
COL II, whereas oBMSCs from sample 1 showed slightly positivity compared with day 0.
On the other hand, expression of AGG was not detected either in oBMSCs from samples 1
and 2, meanwhile little positivity was found in sample 3. Furthermore, COL I expression
changed compared among the samples. Measuring the expression of the multipotency
genes in the oBMSCs cultured in control medium for 21 days, the expression of VIM was
decreased compared with oBMSCs at 0 day of differentiation. Additionally, SOX 2 expres-
sion was significantly increased in oBMSCs from samples 1 and 3 cultured for 21 days in
control medium (Fig 4B).
Fig 3. Osteogenic differentiation of oBMSCs. (A) Ovine bone marrow mesenchymal stromal cells (oBMSCs, n = 4, passages 2nd-5th) at day 0 of
differentiation (left) and after culture for 21 days in non-differentiation control medium (20% FBS/DMEM, middle) and osteogenic-differentiation
medium (right) (Magnification x100). The presence of osteoblasts was assessed by detection of calcium deposits using Alizarin Red (AR) stain
(Magnification x200). (B) Bar graph represents the percentage of area positively stained for AR expressed as the mean ± standard error. 1. * and #
indicates p<0.05. (C) The osteogenic differentiation potential was confirmed by quantitative Real Time Polymerase Chain Reaction (qRT-PCR). The
expressions of osteogenic- and multipotency-specific genes were analyzed. mRNA levels were measured in three independent samples (n = 3) by
qRT-PCR as described in Materials and Methods. Data are expressed as mean ± standard error of the relative expression (REL). The results are
normalized to values obtained for oBMSCs at day 0 of differentiation, considered to equal 1.
doi:10.1371/journal.pone.0171231.g003
Osteochondral Tissue Engineering
PLOS ONE | DOI:10.1371/journal.pone.0171231 January 31, 2017 11 / 26
In vitro osteogenic differentiation of oBMSCs cultured on collagen
sponges and β-tricalcium phosphate ceramic
Histological and immunohistochemical analyses of the osteogenic constructs. Osteo-
genic constructs showed low cellularity on both types of scaffolds, with scant ECM formation.
However, Col I sponges had cells with a cubic morphology resembling osteoblasts (Fig 5A and
5B). Staining for AR and VK was significantly higher on Col I sponges than on bTCP ceramics
(42.99%±2.25% and 10.30%±0.24%; p-value = 0.012, respectively for AR and 6.97%±1.31% and
2.21%±0.93%; p-value = 0.024, respectively for VK) (Fig 5A and 5C). Immunostaining for Col
I and OCN revealed significantly higher positivity for both proteins on Col I sponges than on
bTCP scaffolds (11.85%±1.07% and 2.47%±0.61%; p-value = 0.002, respectively, for Col I
Fig 4. Chondrogenic differentiation of oBMSCs. (A) Ovine bone marrow mesenchymal stromal cells (oBMSCs, n = 3, passages 2nd-5th) in micromass
culture for 21 days in non-differentiation control medium (“t21 Control”; 20% FBS/DMEM) and chondrogenic-differentiation medium (“t21 Chondro”)
(Magnification x100 and x200, respectively). Micromasses were stained with hematoxylin-eosin (HE), Masson´s trichrome (MT), PAS-Alcian blue
(PAS-AB) and safranin O (SO). Immunodetection of type I and type II collagen (Col I and Col II) was assessed on micromasses. (B) The chondrogenic
differentiation potential was confirmed by quantitative Real Time Polymerase Chain Reaction (qRT-PCR). The expressions of chondrogenic- and
multipotency-specific genes were analyzed. Data are expressed as mean ± standard error of the relative expression (REL). The results are normalized to
values obtained for oBMSCs at day 0 of differentiation, considered to equal 1.
doi:10.1371/journal.pone.0171231.g004
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protein and 12.22%±1.46% and 5.51%±0.51%; p-value = 0.002, respectively, for OCN protein)
(Fig 5B and 5C).
Ultrastructural analysis of osteogenic constructs. Constructs of Col I sponges, analyzed
by TEM, showed cells (Fig 6A in dark blue) surrounding the calcium phosphate precipitates
(Fig 6A in black and white). Cells exhibited differing morphologies; round- (Fig 6E), oval- (Fig
6B), star- (Fig 6I) and elongated-shaped (Fig 6D, 6H and 6J), and remained as aggregates (Fig
6B, 6C, 6F and 6G). In these aggregates, cells, containing few small prolongations (black
arrows), were observed to be in contact with each other. Increased numbers of vacuoles (yel-
low arrows) existed at the contact areas between cell membranes. Many calcium phosphate pre-
cipitates were observed, not only in the cytoplasm of the cells (Fig 6D and 6J), but also in the
extracellular space (Fig 6B, 6C, 6F, 6H and 6I). In the cytoplasm, and before being secreted out-
side the cell, these precipitates appeared inside vacuoles (Fig 6D, 6J and 6I; red arrows). Occa-
sionally, these vacuoles were empty, perhaps because the precipitate had already been secreted
outside the cell (Fig 6C, 6I and 6G; red arrowheads). In general, cells were organelle-rich. Gran-
ular endoplasmic reticula with ribosomes (Fig 6D and 6I; white arrow), mitochondria with
Fig 5. Osteogenic differentiation of ovine bone marrow mesenchymal stromal cells (oBMSCs) cultured on Col I sponges and β-tricalcium
phosphate (bTCP) ceramic. (A) Histological evaluation of osteogenic constructs (oBMSCs at passages 3rd and 4th, n = 3) stained with hematoxylin-
eosin (HE), Alizarin Red (AR) and Von Kossa (VK). Magnification x100. (B) Immunohistochemical analysis of the osteogenic constructs immunostained
for type I collagen (Col I) and osteocalcin (OCN). Magnification x100. (C) Bar graph represents the percentage of cells positive for AR, VK staining and
OCN and Col I immunostaining, expressed as the mean ± standard error. * indicates p<0.05
doi:10.1371/journal.pone.0171231.g005
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cristae (Fig 6D, 6J, 6I and 6H; blue arrows) and euchromatic nuclei (Fig 6C, 6E, 6G and 6I)
were observed. In addition, in the cytoplasm of differentiated cells, the accumulation of multiple
matrix vesicles was observed (Fig 6C).
The ultrastructural analysis of bTCP ceramic showed cells (Fig 6K in dark blue), with an
elongated-shape (Fig 6L, 6M, 6R and 6S) and small prolongations (Fig 6L, 6O and 6Q; black
arrows) surrounding the calcium phosphate precipitates (Fig 6K in black and white). These
cells formed aggregates (Fig 6M and 6R) and showed accumulations of roughly fused spherical
material in the cytoplasm (Fig 6M, 6N and 6P; black star). These accumulations were electron-
dense because of their high osmium tetroxide affinity, indicating high lipid content. Further-
more, these accumulations were more abundant on bTCP ceramic than on Col I sponges. Cal-
cium phosphate deposits were only observed outside the cell (Fig 6L, 6N, 6P and 6S), although
it was not possible to distinguish between deposits secreted by the differentiated cells and pre-
cipitates from the bTCP ceramic. In addition, in the cytoplasm of the cells, multiple empty vac-
uoles that could have initially contained such deposits were observed (Fig 6N, 6T and 6Q; red
arrows). In general, cells showed an organelle-rich composition (Fig 6M, 6O, 6Q, 6R and 6S)
with multiple vesicles (Fig 6L, 6M, 6N and 6Q) and euchromatic nuclei (Fig 6L, 6O and 6Q).
Fig 6. Transmission electron microscopy. Images obtained from type I collagen (Col I) and β-tricalcium phosphate (bTCP) ceramic constructs (oBMSCs
at passages 3rd and 4th, n = 2). The different scaffolds are shown in rows. The first two rows (from A to J) are Col I sponges and the last two rows (from K to T)
are bTCP constructs. A, K: semi-thin sections (1 μm) of the constructs embedded in Spurr and stained with toluidine blue (Magnification x200). Scales of
bars: F, 10 μm; B, C, G, H, L, P, Q, 5 μm; D, E, I, J, M, N, O, R, S, 2 μm; T, 1 μm. Black arrows: prolongations; yellow arrows: vacuoles; red arrows: preci-
pitates inside vacuoles; red arrowheads: empty vacuoles; white arrows: rough endoplasmic reticulum; blue arrows: mitochondria; black stars: electron-dense
spheres.
doi:10.1371/journal.pone.0171231.g006
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Energy dispersive X-ray study of Col I constructs. To verify that the deposits found in
the extracellular space and in the cytoplasm of the cells cultured on Col I sponges were composed
of calcium phosphate, an energy dispersive X-ray (EDX) study was performed. The analysis was
performed at different areas of the sample preparations to ascertain its exact composition. These
areas included a region of the precipitate (Fig 7A, highlighted with the number “1”) and a region
of cells (Fig 7A, highlighted with the number “2”). As can be seen in Fig 7B, 7C and 7D, the
main elements found in the precipitate were carbon (47.95%±4.93%) and oxygen (18.77%
±2.86%) followed by calcium (11.87%±0.41%) and phosphate (6.51%±0.19%). These elements
were, however, not detected in the region of cells (Fig 7B, 7C and 7D); instead, carbon (69.725%
±0.95%) and oxygen (9.08%±1.02%) followed by copper (10.11%±0.56%) and zinc (6.41%
±0.11%) were found. The EDX analysis was not performed on the bTCP ceramic constructs
because it was not possible to distinguish between the deposits secreted by the differentiated cells
and the precipitates from the bTCP ceramic.
Morphometric analysis of osteogenic constructs. Cell-free Col I sponges (Fig 8A–8E)
showed by SEM that their general structure were fibrous whereas bTCP (Fig 8K–8O) ceramics
were smoother. Because of the lack of microporosity, cells grew on and adhered to the surface
of bTCP, but not inside, whereas the Col I structure had allowed cell growth throughout the
scaffold, as observed in different sections. On Col I constructs, cells showed different morpholo-
gies from flattened (Fig 8F, 8G and 8H; black arrows) to rounded (Fig 8I and 8J; black arrows),
but only flattened cells were seen on bTCP (Fig 8P–8S; black arrows). Cells presented small pro-
longations on both scaffolds (Fig 8G, 8H, 8P and 8R; red stars).
Furthermore, more volume of ECM was observed in Col I constructs (Fig 8G–8J; black
stars), compared with bTCP constructs (Fig 8Q, 8S and 8T; black stars).
Chondrogenic differentiation of MSCs cultured on collagen sponges in
an in vitro articular cartilage repair model
Although our first goal in the articular cartilage repair model was to produce semicircular
lesions on the cartilage surface, deeper lesions (from side to side) were generated in some of
the replicas (Fig 9A) because of the thinness of the ovine cartilage. Several replicas also had
slivers of native cartilage inside the lesion (Fig 9A; medium results, second row) because of
drill movement during handling. Three representative replicas of worst, intermediate and best
neotissue were evaluated by the ICRS II scale from a total of 7 (2 best, 2 intermediate and 3
worst) (Fig 9A and 9B).
HE staining allowed the observation of neotissue formation inside the lesion (Fig 9A, inter-
mediate and best replicas). Col I scaffolds ranged from barely- (worst replica) to nearly totally-
degraded (best replica) (Fig 9A).
The first parameter analyzed in the adapted ICRS II scoring system, using MT staining, was
“tissue morphology” (Fig 9). This criterion was assessed by analyzing the collagen fiber distri-
bution. The worst results did not show any ECM, scoring a value of 0%. Intermediate results
showed heterogenic and obvious collagen fibers, being an intermediate tissue between fibro-
cartilage and fibrous tissue (25% score). In the best results, collagen fibers were more evident
in the deep zone of the repaired tissue than in the superficial zone (60% value) (Fig 9A and
9B).
The second criteria used to evaluate PG content was “matrix staining” (Fig 9), which was
assessed using SO staining. The results ranged from 0% (the worst) to 35% (the best).
The next two variables, analyzed by HE staining, were “cell morphology” and “chondro-
cyte clustering” (S2A Fig). In the worst results, 10% of the cells were rounded, while in the
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intermediate and best results, approximately 50–55% of the cells were rounded. All the rep-
licas showed absence of clusters, scoring 100%.
The next item studied was “surface architecture.” The worst results showed disruptions on
the surface (5%); while intermediate results revealed an upper surface smoother than the lower
one (50%). The best replicas showed lack of disruptions, delaminations and loosenings, scor-
ing 80%. The final criterion analyzed, “integration with native cartilage,” ranged from 0%
(worst results) to 75–90% (intermediate and best replicas, respectively). Finally, to score “over-
all assessment,” the statistical mean of the values for all 6 parameters analyzed was calculated.
The worst cartilage repair score was 19%, indicating fibrous tissue; the intermediate cartilage
repair scored 52%, indicating a fibrocartilage tissue; and finally, the best neotissue formed was
graded in the midrange of fibrocartilage and hyaline cartilage (70%).
Some replicas have been immunostained for Col I, Col II and Agg. The collagen content of
the repaired tissue was absent in the worst results, whereas in the intermediate and best repli-
cas, both ECM proteins were present (Fig 9A). Aggrecan was also absent in the worst results,
but slightly present in the other two results.
Fig 7. Energy dispersive X-ray (EDX) analysis performed on the type I collagen (Col I) constructs. (A) Images obtained by scanning
electron microscopy (SEM) showing the two areas analyzed; the number “1” indicates a precipitate, and the number “2” indicates a cell
aggregate. (B) Spectrum of the two regions analyzed showing the elements detected: Spectrum 1 corresponding with a precipitate and
spectrum 2 with a cell aggregate. (C) Bar graph represents the percentage of the elements found in five different analyzed spectra; three from
the analyzed precipitate and the other two from the cell aggregate. (D) Map of C, Ca and P distribution analyzed in the whole sample.
doi:10.1371/journal.pone.0171231.g007
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Discussion
Previous studies have reported the isolation of oMSCs from bone marrow [5, 23–25], adipose
tissue [34–36], umbilical cord blood [36, 37], peripheral blood [21, 38], amniotic fluid [39, 40],
dermis [41] and periodontal ligament [42]. Despite the increasing use of sheep as a large ani-
mal model for tissue engineering, because of their similarities to humans in size, joint architec-
ture and healing mechanisms [25], ovine MSCs have been poorly characterized compared to
human MSCs [24]. Accordingly, the aim of this study was to first perform an extensive mor-
phologic, immunophenotypical and functional characterization of isolated oBMSCs. Second,
the in vitro osteogenic differentiation of oBMSCs cultured on Col sponges and bTCP ceramic
was studied, and finally, the chondrogenic differentiation of oBMSCs cultured on Col sponges
in an in vitro articular cartilage repair model was analyzed.
For our study, oBMSCs were obtained from iliac crest aspirates, the most common
approach described in the literature, to collect bone marrow [2, 13, 15, 17, 23–25, 43]. For
oBMSCs isolation, the simplest and easiest protocol for successful isolation of hBMSCs was
used, omitting two steps sometimes applied in other oBMSCs isolation protocols: density gra-
dient centrifugation [2, 18, 19, 25, 34, 44–46] and erythrocyte lysis [15]. Several reports simply
Fig 8. Scanning electron microscopy (SEM). SEM images obtained from type I collagen (Col I) and β-tricalcium phosphate (bTCP) ceramic constructs
(oBMSCs at passages 3rd and 4th, n = 2). Cell-free Col I sponges (W/O CELLS, A-E) and Col I constructs with cells (W/CELLS, F-J) are shown in the two
first rows. Cell-free bTCP scaffolds (W/O CELLS, K-O) and bTCP constructs with cells (W/ CELLS, P-T) are shown in the last two rows. Scales of bars: K,
P 700 μm; L, Q 400 μm; A, F, M, R 200 μm; B, G, N, S 50 μm; C, H 40 μm; D, I 20 μm; E, J, O, T 10 μm. Black arrows: cells; black stars: extracellular matrix;
red stars: cell prolongations.
doi:10.1371/journal.pone.0171231.g008
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assumed that cells isolated from bone marrow were oBMSCs, omitting any further extensive
characterization process [2].
In our study, cells with adherence to culture plastic and a typical spindle-shaped fibroblast-
like morphology were isolated. As Rentsch et al. [46], Al Faqeh et al. [17] and McCarty et al.
[25] described, we also observed that these cells presented prolongations and typical fibro-
blast-like morphology. oBMSCs have been reported to be smaller [46] and to show an in vitro
higher proliferation rate and longer life span [28] than their human counterparts, although we
did not test these parameters.
Following the International Society of Cell Therapy criteria [47], hMSCs have to express at
least the CD73, CD90 and CD105 cell surface markers. There is little information about the
cell surface antigen profile of isolated oBMSCs because of the limited availability of antibodies
specific for sheep [25]. This lack of information is also due to human antibodies not having
Fig 9. Chondrogenic differentiation of ovine bone marrow mesenchymal stromal cells (oBMSCs) on type I Col (Col I) sponges in an in vitro
cartilage repair model. (A) Images of the histological analyses performed in the best, intermediate and worst replicas (oBMSCs at 4th passage,
n = 2; 7 cartilage discs from 3 animals), stained with hematoxylin-eosin (HE), Safranin O (SO), Masson´s trichrome (MT) and immunostained for
aggrecan (Agg), collagen type I and II (Col I and Col II). Inmunostainings were counterstaining with H-E. Magnification x40. (B) Table that represents
the cartilage repair scoring according to the modified ICRS II scale [32] of each replica.
doi:10.1371/journal.pone.0171231.g009
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cross-reactivity with sheep antigens. Therefore, when using human antibodies, the absence of
expression of such cell surface markers needs to be interpreted with caution [27]. The antigen
expression pattern of oBMSCs has been reported to be positive for anti-human CD44 and
CD105, and negative for anti-ovine CD45 antibodies [5]. Adamzyk et al. [19] observed only in
some specimens that the CD73 expressed by the oBMSCs which was able to bind the selected
anti-human CD73 antibody, and Martı´nez-Lorenzo et al. [35] observed high positivity for
anti-human CD90, but very low positivity for anti-human CD73 and CD105 antibodies. In
agreement with the results published in the literature, antibodies with human reactivity for
CD73 [18], CD90 [18, 25] and CD105 [18, 25, 44] did not react positively with our oBMSCs.
This absence of expression may be due to the lack of cross reactivity of these antibodies
between species. Consistent with the literature, we found absence of anti-rat CD45 positivity
[5, 25, 44], indicating that the cells were not of hematopoietic origin. Moreover, we observed
uniformly high cross-reactivity for antibodies anti-human CD29, anti-ovine CD44 and anti-
human CD166, as described by others [13, 23, 25, 44]. These markers have been associated
with human bone marrow stromal, adipose and dental pulp cells [23]. oBMSCs isolated by
Zannettino et al. [28] also were positive for antibodies anti-ovine CD29 and anti-mouse CD44.
Furthermore, we found positivity for an embryonic stem cell marker, hSSEA4, but it was not
expressed consistently in all the samples. Therefore, taking these results together, the oBMSCs
cell-surface antigen profile seems similar to the expression profile of hBMSCs, in that they
express markers of mesenchymal and embryonic stem cells [33, 48].
In the literature, there are some studies that did not perform any functional characteriza-
tion of oBMSCs [2, 15], isolating these cells only by culture-plastic adherence. Other studies
assessed differentiation potential into only one cell lineage, including Martı´nez-Lorenzo et al.
[35], who just tested chondrogenic differentiation, and Reichert et al. [23], who just tested
osteogenic differentiation. Some studies have assessed the capacity of oBMSCs to differentiate
into the three lineages [16, 28, 44–46], while other studies have performed both histological
and RT-PCR analysis of differentiation [5, 25]. In other reports, published before the complete
sequencing of the sheep genome [26], multiple sequence alignment of bovine, human, and rat,
among other species, were used for RT-PCR primer design [2, 20, 25]. Therefore we performed
a multipotent differentiation analysis in which qRT-PCR primers were synthesized, based only
on the sheep genome, to quantify specific genes for each cell lineage. Uniquely in our study,
assessments of the gene expression of multipotency markers, such as VIM and SOX2, were
also assessed. These studies were performed at 0 and 21 days of differentiation, not only in
stimulated differentiation media, but also in non-stimulated control DMEM medium.
To achieve adipogenesis, a human differentiation medium was initially used without suc-
cess (data not shown), confirming results obtained by Mrugala et al. [5]. Their report indicated
that the stimulus needed to induce adipogenic differentiation differs for human and ovine
cells. Thus, adipogenic differentiation did not occur when oBMSCs were cultured in the media
typically used to induce hBMSC adipogenesis. Complementation of the differentiation media
with dexamethasone and rosiglitazone was needed to trigger the ovine adipogenic differentia-
tion process [5, 16, 49]. In our experimental culture conditions, including dexamethasone and
rosiglitazone, oBMSCs differentiated adipogenically, as shown by our observations of cyto-
plasmic lipid droplets, an trended to increase expression of adipogenic genes (LPL and FABP4),
and a to decrease expression of multipotency (VIM and SOX2) genes. Our results are in accor-
dance with previous reports [5, 21, 24, 25, 28, 44, 45]. The effect of adipogenic culture media on
differentiation of oBMSCs was studied by Adamzyk et al. [19]. These authors obtained oBMSC
adipogenesis without donor variations, but with a larger variation due to media used. In con-
trast, they found that variation in osteogenic differentiation was influenced by donor, protocol
and preculture-dependent variations. After 21 days of osteogenic stimulation, we histologically
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observed the presence of calcification and an increased expression of OP and OCN at the gene
level. These results agree with previous reports [5, 16, 21, 23–25, 28, 44]. Moreover, after 21
days in control culture media, we also observed slight AR staining and increased expression of
the OP and OCN specific-lineage genes in some samples. In the absence of stimulation, high
basal levels of OP were also obtained by Mrugala et al. [5], possibly due to growth factors that
stimulate osteogenesis in the FBS included in their culture media [50].
We observed that oBMSCs were able to differentiate towards chondrocyte-like cells only
when TGFβ3 was added to the chondrogenic culture medium, as previously reported by Mru-
gala et al. [5]. However, Martı´nez-Lorenzo et al. [35] did not obtain good chondrogenesis
using TGFβ3 exclusively, finding it necessary to add bone morphogenetic protein-6 (BMP-6).
In our study, oBMSCs were highly positive for CD44, a putative marker of enhanced chondro-
genic capacity [51]. The ability of oBMSCs to trigger chondrogenesis was assessed using a pel-
let culture system, as previously reported [5, 15, 24]. This three-dimensional culture enables
stronger cell-to-cell contact [52] allowing increased presence of Col II throughout the matrix
[16]. Histologically, we found the presence of PG and Col in the ECM of pellet cultures. The
expression of AGG, one of the main PGs of ovine [20] and human [53] cartilage ECM was
only evident in stimulated cells, indicating the success of oBMSC chondrogenesis.
Applications of MSCs, especially in combination with biomaterials, have raised optimism
for future therapies to repair tissues including cartilage and bone [19]. TCP resorbable ceram-
ics are widely used as bone fillers in orthopaedic surgeries for treatment of long bone fractures
[28]. Gupta et al. [54] compared cell-enriched TCP grafts, TCP alone, and autografts in an in
vivo model. They found that TCP alone could not serve as an effective graft in the absence of
osteoprogenitor cells, while autologous bone marrow with TCP increased bone formation. El-
Jawhari et al. [55] found that the addition of Col to natural bovine bone scaffolds improved the
attachment, survival and proliferation of hBMSCs. Using histology and electron microscopy,
we observed more cell attachment, ECM deposition and osteogenic phenotype in Col sponges
than in bTCP ceramics. Although our cells express high levels of CD29 we found poor distri-
bution of cells within Col I scaffolds. Some subclasses of this marker are associated with more
efficient binding to Col-based scaffolds [28]. The use of Col I scaffolds possesses various bene-
ficial properties for clinical application, including biodegradability, low immunoreactivity and
enabling the transport of nutrients [15, 56]; these properties have led to their wide use in tissue
engineering [56].
Histologically, we found osteoblasts in Col constructs, as previously described in in vivo
bone repair using MSCs with platelet-rich plasma (PRP)[34]. We also confirmed the presence
of osteoblasts in Col constructs by detecting OCN, a bone protein exclusively synthesized by
these cells [57]. Moreover, VK and AR staining confirmed the presence of bone cells by the
specific presence of insoluble calcium phosphate salts [57] and calcium deposits [58] in the
extracellular spaces.
The EDX analysis provides a useful tool for elemental quantification in tissues, allowing the
semi-quantification of the amounts of Ca and P in bone [59]. In our study, we performed an
EDX analysis to confirm the presence of phosphate-calcic precipitates secreted by osteogenic
differentiated cells in Col constructs. We obtained the same Ca/P ratio in these deposits as that
described by Perdikouri et al. [59] in a rat fracture healing model. Melrose et al. [60] also
reported that Ca and P were the major elements detected in calcic deposits formed in sheep
intervertebral discs.
Scanning electron microscopy showed different cell morphologies on bTCP and Col bio-
materials. Schmitt et al. [57] also found different morphologies depending on the surface
topography of different types of scaffolds. Thus, in some biomaterials cells were capable of
growth inside the scaffold while in others, cells were flattened and more dispersed on the
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surface. On bTCP, oBMSCs were also flattened but dispersed along the outer side of the bio-
material, whereas in Col biomaterial, cells could grow throughout the scaffold because of its
higher porosity. Using TEM, we observed that osteogenic differentiated oBMSCs acquired an
osteoblast-like phenotype on both biomaterials, as also described by Ozen et al. [61]. Desantis
et al. [62] found two cell types in oBMSC pellets, electron-dense and electron-lucent, while we
only observed one cell type. Our osteogenic differentiated cells were similar to their electron-
lucent counterparts.
In vitro testing provides standardized and quantifiable information about cytotoxicity, cell
proliferation and differentiation capacity rate more easily than in vivo testing. Moreover, it is
accepted that in vitro testing is used as a first stage test to avoid the unnecessary use of animals
in materials testing [63]. However, it is impossible to create in vitro bone repair models because
it is not possible to maintain long-term bone cultures.
Several authors [15, 20] have developed chondrogenic in vitro studies using ovine cells and
different types of scaffolds. Endres et al. [20] cultured ovine chondrocytes on polyglycolic acid
(PGA)-fibrin biomaterials. They found that chondrocytes were surrounded by ECM, rich in
PG, and had the homogenous distribution of Col II characteristic of hyaline cartilage. Schulz
et al. [15] tested the in vitro formation of cartilaginous grafts using Col I hydrogels and ovine
cells. They compared the phenotype of constructs from ovine chondrocytes and oBMSCs and
achieved better results using the latter. However, these previous studies did not test the con-
structs in a native cartilage environment as we did. We created an ovine cartilage repair model
and evaluated the capacity of repair using oBMSCs and Col I constructs.
Using a modified ICRS II scale [32], our construct replicas obtained scores from 19%
(fibrous tissue) to 70% (fibrocartilage/hyaline cartilage) out of 100% (hyaline cartilage). We
should point out that this scale was designed to evaluate in vivo osteochondral human repair.
On one hand, only histological parameters were taken into account. On the other hand, in
human cartilage the presence of chondrocyte clusters is associated with a pathological state,
unlike ovine cartilage where it is usual to find more than one chondrocyte per lacuna (S2B Fig)
[20, 32].
In our work, variability between replicas was observed. The small lesion size due to the thin-
ness of ovine cartilage could contribute to this variability between replicas [2]. It is necessary
to consider that the generation of the lesion disrupts cartilage ECM and that can cause lost of
PGs and collagens, as we could observe by immunostaining. Other limitations of this study
may be the lost of PGs because of the culture [64], time of culture and the absence of mechani-
cal stimuli.
We used shorter culture times (2 months) than those described in the literature [65]. Math-
ematical models have predicted a timeframe in vivo of at least 18 months to obtain completely
mature cartilage. This agrees with clinical studies that demonstrate that cartilage repair is a
slow process [65]. However, longer culture times considerably increase the risk of culture con-
tamination and cartilage degradation [66]. Likewise, the absence of mechanical stimuli may
impact adversely on the quality of newly formed repair tissue. However, our model allows ana-
lyzing cartilage samples from the same donor using different study variables, and testing engi-
neered constructs in the native cartilage environment.
In conclusion, the results from the present study demonstrated that oMSCs have been effec-
tively isolated from bone marrow aspirates and showed morphological, phenotypical and func-
tional properties similar to those observed in their human counterparts. Further optimization
would be needed to use Col I scaffolds as temporary matrices for cell proliferation, migration,
and osteochondral differentiation of oBMSCs. Additionally, in an in vitro cartilage repair
model, we demonstrated that oBMSCs cultured on Col I sponges can successfully form
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fibrocartilage/hyaline cartilage tissue. Finally, this study suggests that oBMSCs may have
potential use in osteochondral engineering.
Supporting Information
S1 Fig. Phenotypic characterization of oBMSCs. (A) Phenotypic characterization by flow
cytometry of a representative population of oBMSCs for markers characteristic of MSCs and
hematopoietic cells, that did not show positivity and/or reactivity with oBMSCs (B) Pheno-
typic characterization by flow cytometry of mononuclear cells from ovine blood, for different
clones of anti-CD45 antibody.
(TIF)
S2 Fig. Histology of the cartilage and in vitro cartilage model. A) Images of hematoxylin-
eosin (H-E) staining and type II Collagen (Col II) immunostaining performed in the best,
intermediate and worst replicas. B) Images of H-E, Masson’s Thricrome (MT) and Safranin O
(SO) staining and Col II, Col I and Aggrecan (Agg) immunostaining, performed in a cultured
biopsy of ovine cartilage.
(TIF)
S1 File. Individual data points underlying means and deviations of: (Sheet “Cytometry”)
flow cytometry percentage of positivity results, (Sheet “qRT-PCR”) Relative expression
(REL) of different genes for multipotent differentiation analyzed by real time PCR and,
(Sheet “%Staining”) histological and immunohistochemical percentage of area stained or
immunostained.
(XLSX)
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